Delivery Order SPE2DB22D3501-SPE2DB24FVN05
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, involves the supply of pharmaceutical products, specifically TAVNEOS 10 MG CAPSULE 180S, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,104.36 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 20, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States and has extensive experience in providing a wide...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tavneos 10 mg capsules (180-count units) with a ceiling value of $10,218.17. This firm fixed-price delivery order, which must be completed by September 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award, valued at $10,375.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that serves as a critical supplier to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $10,011.43, is a delivery order awarded under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,733.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564977921 TALVEY 3 MG/1.5 ML VIAL 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
- The federal contract award is for the delivery of pharmaceutical products and medical supplies, with a ceiling value of $25,580.72, awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of May 19, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a Delivery Order valued at $20,275.30 with a completion date of May 14, 2024. The contract was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and is a firm fixed-price contract for the provision of pharmaceutical products and medical supplies. Amerisourcebergen is a major supplier of prescription medications, over-the-counter drugs, and medical...
- This federal contract award, valued at $10,137.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion...
- This federal contract award, valued at $12,990.43, was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which runs through April 30, 2024, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract has a ceiling value of $16,491.28 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVN05Delivery Order
This federal contract award is for the delivery of Tavneos 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency, by the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $10,104.36 and is a firm-fixed-price delivery order with a completion date of May 23, 2024. The contract is not set aside for any specific business type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 5/2/24 |